1. Introduction
===============

Severe acute respiratory syndrome-coronavirus (SARS-CoV) is the etiological agent causing the global outbreak of atypical pneumonia in 2003. The SARS-CoV genome carries a minimum of 14 open reading frames (ORFs; [@bib19], [@bib25], [@bib15], [@bib37]), encoding replicases, various structural proteins (including spike, envelope, membrane, nucleocapsid), and a number of accessory proteins ([@bib37], [@bib25], [@bib19]). A subset of these viral proteins, including 3a, are only found in SARS-CoV but not other coronaviruses ([@bib25]). Understanding the molecular functions of these SARS-CoV-specific proteins would shed light on the life cycle of the virus.

The SARS-CoV 3a locus, also known as X1 ([@bib25]), ORF3 ([@bib19]) and U274 ([@bib32]), encodes a 274 a.a. protein ([@bib19]). The 3a protein shows cytoplasmic ([@bib22], [@bib32], [@bib43], [@bib44], [@bib48]) and plasma membrane ([@bib11], [@bib18], [@bib32]) localization in both transfected and viral-infected cells. 3a possesses three transmembrane regions (a.a. 34--56; 77--99; 103--125) in its N-terminus, and an intracellular C-terminal region ([@bib19], [@bib25]). The central region of 3a carries several conserved sequences which includes a cysteine-rich domain (a.a. 127--133), a Yxxϕ domain (a.a. 160--163) and a diacidic domain (a.a. 171--173), which is then followed by the C-terminal domain (a.a. 209--264) ([@bib22], [@bib19], [@bib46], [@bib32], [@bib43]). The cysteine-rich domain is known to be responsible for homo- and hetero-dimerization of 3a, which is crucial for its ion channel activity ([@bib18]). To date, the functional significance of 3a\'s ion channel activity on its function is still not well defined. The Yxxϕ domain is a protein internalization signal which is involved in clathrin-mediated endocytosis ([@bib28]); while the diacidic domain is a trafficking signal responsible for efficient endoplasmic reticulum (ER) protein export ([@bib21]). Both the Yxxϕ and diacidic domains play important roles in intracellular protein trafficking of 3a, and a deletion mutant (a.a. 160--173) which uncovers these domains abolishes the localization of 3a to the cell surface ([@bib32]). Further, the 3a C-terminal domain (a.a. 125--200) has been demonstrated to possess RNA-binding activity ([@bib26]).

Expression of 3a is detected in patients' intestinal surface enterocytes and pneumocytes ([@bib46], [@bib43], [@bib3]). Both its physical interactions with other viral structural proteins including Spike, Envelope and Membrane ([@bib32]) and its incorporation into newly packaged matured SARS-CoV virions ([@bib27], [@bib11]) suggest that 3a plays a structural role in the SARS-CoV life cycle. Apart from being a viral structural protein, 3a has been shown to regulate various cellular responses of host cells, including the up-regulation of fibrinogen gene expression ([@bib33]), and augmentation of IL-8 and NF-κB promoter activities ([@bib12]), possibly through its RNA-binding activity ([@bib26]).

It has been reported that apoptosis initiates viral cytopathic effect in SARS-CoV-infected cells ([@bib24], [@bib1], [@bib41]). Consistent with the viral cytopathological studies, a number of SARS-CoV proteins, including 3a ([@bib39], [@bib16]), are found to be pro-apoptotic ([@bib31], [@bib35], [@bib36], [@bib30], [@bib7], [@bib17], [@bib43], [@bib45], [@bib42], [@bib47], [@bib13], [@bib14], [@bib4]). Previously, we and others showed that both caspase-8 ([@bib16], [@bib23]) and cytochrome *c* ([@bib23], [@bib39]) are involved in 3a-induced apoptosis. More recently, [@bib23] reported that Bax, p53 and p38 MAP kinase also play roles in 3a-induced apoptosis.

The SARS-CoV 3a protein appears to have multiple functions, including apoptosis induction. Although the cysteine-rich, Yxxϕ and diacidic domains are well-known protein motifs on 3a ([Fig. 1](#fig1){ref-type="fig"}A), it still remains unclear how these domains are involved in 3a functions. In the present study, we performed a structure--function study of 3a with an aim to investigate the roles of these domains in its pro-apoptotic function *in vitro* and *in vivo*. In addition the cysteine-rich domain had previously been shown to be critical for 3a\'s ion channel activity ([@bib18]), our data further illustrate that the ion channel activity is indispensible for caspase-dependent apoptosis of 3a.Fig. 1Subcellular localization of wild type and mutant SARS-CoV 3a proteins in Vero E6 cells. (A) Mutagenesis scheme of this study. (B--E) Subcellular localization of wild type and mutant 3a proteins in Vero E6 cells. Wild type 3a protein (3a-WT) displayed plasma membrane and punctate cytoplasmic staining pattern (B). The cysteine-rich domain mutant protein 3a-CS lost the plasma membrane localization, and concentrated in the cytoplasm and the perinuclear region (C). Both 3a-YA (D) and 3a-DE (E) mutant proteins showed cytoplasmic localization and fractional plasma membrane localization was retained. Different degrees of protein aggregation were also observed in 3a-YA and 3a-DE mutant proteins (D and E). ER-Tracker™ Red was used as a counter-stain to label the endoplasmic reticulum (shown in red). Scale bar represents 16 μm. (F) Quantification of subcellular distribution of 3a-WT and mutant 3a proteins. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of the article.)

2. Materials and methods
========================

2.1. Generation of 3a mutant constructs
---------------------------------------

The wild type *pUAST-3a-WT* construct ([@bib39]) was used as template to generate three mutant *3a* constructs *pUAST-3a-CS*, *-3a-YA* and *-3a-DE* ([Fig. 1](#fig1){ref-type="fig"}A). Primers used were CS-F: 5′-TTA TGA GAT CTT GGC TTT CTT GGA AGT CCA AAT CCA A-3′; CS-R: 5′-TTG GAT TTG GAC TTC CAA GAA AGC CAA GAT CTC ATA A-3′; Y160A-F: 5′-CTG TAT ACC AGC TAA CAG TGT CAC-3′; Y160A-R: 5′-GTG ACA CTG TTA GCT GGT ATA CAG-3′; DE-F: 5′-CGT TAC TGC AGG TGC CGG CAT TTC A-3′; DE-R: 5′-TGA AAT GCC GGC ACC TGC AGT AAC G-3′. All mutations were confirmed by DNA sequencing. For mammalian cell expression, both wild type and mutant *3a* genes were subcloned into *pcDNA* vectors to generate *pcDNA3.1-3a* or *pcDNA6-3a-EGFP* constructs. Standard overlapping PCR strategy was used to generate *pcDNA3.1-3a-CS-YA-DE* triple mutant construct.

2.2. Mammalian cell culture and transient transfection
------------------------------------------------------

The African green monkey kidney cell line Vero E6 was maintained at 37 °C in Dulbecco\'s modified Eagle\'s medium (DMEM, Invitrogen) containing 10% heat-inactivated fetal bovine serum (Gibco-BRL), streptomycin (100 g/ml) and penicillin (100 U/ml). Cells were seeded onto 24-well plates 24 h prior to transfection, and 0.3 μg of DNA was used for transient transfection. Lipofectamine (Invitrogen) and PLUS transfection reagents (Invitrogen) were used according to manufacturer\'s instructions.

2.3. Immunofluorescence staining of Vero E6 cells
-------------------------------------------------

Cells were seeded onto coverslips at a density of 1.2 × 10^5^  cells/coverslip. After transient transfection, cells were fixed with 3.7% formaldehyde in 1× PBS for 15 min and then permeabilized by 1% Triton X-100 in 1× PBS for 5 min. After blocking with 1% goat serum in 1× PBS for 30 min, cells were incubated with mouse anti-SARS-3a antibody X98 (1:40; [@bib39]) at 4 °C overnight. Alexa Fluor 488 goat anti-rabbit IgG (H + L) (1:400; Invitrogen) was used as secondary antibody. Endoplasmic reticulum was labeled by ER-Tracker™ Red (5 μM, BODIPY^®^ TR glibenclamide, Invitrogen) and cell nuclei were stained with Hoechst 33342 (5 μM, trihydrochloride trihydrate, Molecular Probes) at room temperature for 10 min. Fluorescent images were captured using an Olympus BX51 upright fluorescence microscope or a Bio-Rad confocal microscope.

2.4. Caspase assays and potassium channel blockers treatment
------------------------------------------------------------

Caspase activity assays were measured using the Caspase-Glo^®^8 and Caspase-Glo^®^9 assay systems (Promega) according to manufacturer\'s instructions. Cell permeable synthetic caspase inhibitors (Merck) z-VAD-fmk, z-IETD-fmk and z-LEHD-fmk were dissolved in DMSO. Potassium channel blockers barium chloride (Ba) and 4-aminopyridine (AP) were dissolved in sterile distilled water. Vero E6 cells transiently transfected with *3a* constructs were treated with caspase inhibitors (50 μM in 1% DMSO) at 48 h post-transfection, and cells were further incubated for another 24 h. For potassium channel blockers treatment, *3a*-transfected Vero E6 cells were treated with Ba or AP at 24 h post-transfection, and cells were then further cultured for another 48 h. After treatments, cells were subjected to immunofluorescence staining as described above.

2.5. Electrophysiology
----------------------

The ion conducting property of 3a was assessed by whole-cell patch clamp. Human embryonic kidney (HEK) 293 cells were transfected with GFP-tagged *3a-WT-*, *3a-CS*, *3a-YA* or *3a-DE* constructs. Twenty-four hours after transfection, cells were trypsinized and seeded on poly-[l]{.smallcaps}-lysine-coated coverslips. Single cells with GFP fluorescence were selected for patch clamp recording. Whole cell currents were recorded by an EPC9 patch clamp amplifier (HEKA) controlled by Pulse software (HEKA). The intracellular solution contained in mM: 140 KCl, 5 NaCl, 2 MgCl~2~, 10 Hepes, at pH 7.2. Bath solution contained in mM: 140 NaCl, 5 KCl, 2 MgCl~2~, 1 CaCl~2~, 10 glucose, 10 Hepes, at pH 7.4. The voltage clamp protocol consisted of rectangular voltage steps from +100 to −100 mV in 20 mV increments applied from a holding potential of −60 mV. Whole cell currents were recorded before and 5 min after 10 mM Ba application ([@bib18]). The experiments were performed at room temperature. The data was analyzed with PulseFit software (HEKA).

2.6. Western blotting
---------------------

Western blotting was performed as described previously ([@bib40]), and subcellular fractionation was performed according to ([@bib8]). Primary antibodies used were anti-Bid (1:2000; BD Biosciences), anti-cytochrome *C* (1:2000; Abcam), anti-glutamate dehydrogenase (GDH; 1:1000; US Biological) and anti-β-tubulin (1:10,000; Developmental Studies Hybridoma Bank, University of Iowa, Iowa City, IA, under the auspices of the National Institute for Child Health and Human Development), and secondary antibodies used were goat anti-mouse IgG (H+L) peroxidase conjugate (1:2,500; Abcam) and goat anti-rabbit IgG (H + L) peroxidase conjugate (1:4000; Cell Signaling).

2.7. *Drosophila* genetics
--------------------------

Fly strains were grown at 29 °C on standard cornmeal medium supplemented with dry yeast. The *gmr-GAL4* driver line was obtained from Bloomington *Drosophila* Stock Center and the *UAS-3a-WT* line was previously described in ([@bib39]). Standard microinjection procedure was employed to generate mutant *3a* transgenic lines (*UAS-3a-CS*, *UAS-3a-YA* and *UAS-3a-DE*). Using RT-PCR, expression level of all *3a* transgenes was found to be comparable (data not shown).

2.8. Scanning electron microscopy of adult fly eyes
---------------------------------------------------

In brief, 2--3-day-old adult fly heads were fixed in 2.5% glutaraldehyde (EM grade, Electron Microscopy Sciences) in phosphate buffer (pH 7.4) for 4 h, then post-fixed with 1% osmium tetroxide (Electron Microscopy Sciences), dehydrated to 100% ethanol and critical-point dried with liquid CO~2~. Gold--palladium-coated specimens were examined with a JEOL JSM-6301FE microscope operated at 5 kV ([@bib5]).

2.9. Acridine orange staining of *Drosophila* larval eye discs
--------------------------------------------------------------

Acridine orange (AO) staining of third-instar larval eye discs was performed as previously described ([@bib10]). Larvae of corresponding genotypes were fed on either unmodified standard cornmeal medium as described above or medium supplemented with Ba since first instar larval stage. Both 1 and 10 μM Ba gave similar results. Eye disc images were captured using an Olympus BX51 upright fluorescence microscope or a Leica NT confocal microscope.

2.10. Statistical analyses
--------------------------

Statistical analyses were performed using Student\'s *t*-test. Data were presented as means + S.E.M. and *p*-values \< 0.05 were considered statistically significant.

3. Results
==========

3.1. Subcellular localization of SARS-CoV 3a protein and its mutants in Vero E6 cells
-------------------------------------------------------------------------------------

We performed site-directed mutagenesis on three domains of 3a, cysteine-rich (3a-CS; C127S C130S C133S), YXXϕ (3a-YA; Y160A) and diacidic (3a-DE; E171A D173A), in an attempt to investigate the functional significance of these regions on 3a function *in vitro* and *in vivo* ([Fig. 1](#fig1){ref-type="fig"}A). Immunofluorescence staining was first performed on these mutant 3a proteins in Vero E6 cells. We found that wild type 3a (3a-WT) protein localized to the plasma membrane ([Fig. 1](#fig1){ref-type="fig"}B and F), and also displayed a punctate cytoplasmic staining pattern ([Fig. 1](#fig1){ref-type="fig"}B and F). In contrast to 3a-WT, the 3a-CS mutant protein lost the plasma membrane localization and became more concentrated in the cytoplasm and the perinuclear region ([Fig. 1](#fig1){ref-type="fig"}C and F). Similarly, the plasma membrane localization of 3a-YA ([Fig. 1](#fig1){ref-type="fig"}D and F) and 3a-DE ([Fig. 1](#fig1){ref-type="fig"}E and F) mutants was partially reduced with a concomitant increase in cytoplasmic signals.

3.2. Protein domains required for inducing 3a\'s caspase-dependent apoptosis
----------------------------------------------------------------------------

We next determined whether these mutations would affect 3a\'s pro-apoptotic function. Previously, we demonstrated the pro-apoptotic properties of 3a-WT in Vero E6 cells using multiple methodologies, including nuclear condensation, DNA fragmentation and TUNEL assay ([@bib16]). Here, we used nuclear condensation as the indicator to assess the pro-apoptotic potential of 3a mutants ([Fig. 2](#fig2){ref-type="fig"} ). Consistent with previous findings ([@bib16]), we showed that up to 60% of 3a-WT-expressing Vero E6 cells displayed nuclear condensation ([Fig. 2](#fig2){ref-type="fig"}A). To determine the roles of CS, YA and DE motifs in 3a-induced apoptosis, we generated a 3a-CS-YA-DE triple mutant and examined its ability to induce nuclear condensation. When compared with 3a-WT, we observed a ∼5-fold reduction of the number of condensed nuclei in cell population expressing the 3a-CS-YA-DE triple mutant protein ([Fig. 2](#fig2){ref-type="fig"}B). Unlike 3a-CS-YA-DE triple mutant, cells expressing single mutant proteins (3a-CS, 3a-DE and 3a-YA) displayed more prominent nuclear condensation ([Fig. 2](#fig2){ref-type="fig"}C). This indicates that CS, YA and DE motifs in 3a each contribute independently and significantly to apoptosis induction.Fig. 2Wild type and mutant SARS-CoV 3a proteins possess caspase activities and cause nuclear condensation in Vero E6 cells. (A) Expression of wild type 3a protein (3a-WT) induced nuclear condensation (arrows) in Vero E6 cells. Scale bar represents 16 μm. (B) Vero E6 cells transfected with 3a-WT construct showed nuclear condensation while cells transfected with the 3a triple mutant (3a-CS-YA-DE) construct showed a much reduced level of nuclear condensation. At least 100 cells were counted in each experiment. *\*p* \< 0.05, 3a-CS-YA-DE triple mutant versus 3a-WT control. (C) Vero E6 cells transfected with 3a-WT and mutant 3a (3a-CS, 3a-YA and 3a-DE) constructs displayed different degrees of nuclear condensation. Nuclear condensation induced by 3a-WT, but not mutant 3a proteins, was inhibited by caspase-8 inhibitor II (z-IETD-fmk) and caspase-9 inhibitor I (z-LEHD-fmk). ^*\#*^*p* \< 0.05, caspase inhibitor-treated 3a-WT cells versus 3a-WT control; *\*p* \< 0.05, 3a mutant-expressing cells versus 3a-WT-expressing cells. At least 100 cells were counted in each experiment. (D) General caspase inhibitor (z-VAD-fmk) significantly reduced nuclear condensation induced by 3a-WT protein in Vero E6 cells. At least 100 cells were counted in each experiment. *\*p* \< 0.05, caspase inhibitor-treated 3a-WT cells versus 3a-WT control. (E and F) Caspase-8 and -9 activities were detected in Vero E6 cells transfected with 3a-WT construct but these activities were significantly reduced in mutant 3a-expressing cells. *\*p* \< 0.05, 3a mutant-expressing cells versus 3a-WT-expressing cells.

Caspase-8 and -9 are enzymes that mediate the cell surface death receptor- and mitochondria-mediated apoptotic pathways, respectively ([@bib6]). We have previously demonstrated a role of caspase-8 in 3a-induced apoptosis ([@bib16]). Here, we found that both caspase-8- and -9-specific inhibitors significantly suppressed nuclear condensation induced by 3a-WT in Vero E6 cells ([Fig. 2](#fig2){ref-type="fig"}C). This indicates 3a triggers apoptosis through both the death receptor- and mitochondria-mediated pathways. When we treated 3a-WT-expressing Vero E6 cells with a broad-spectrum caspase inhibitor z-VAD-fmk ([@bib38]) which blocks caspase-dependent apoptosis in general, a similar level of inhibition was again observed ([Fig. 2](#fig2){ref-type="fig"}D). Consistent with the caspase inhibition results, we further showed that the activities of caspase-8 and -9 were significantly reduced in all 3a mutant-expressing cells ([Fig. 2](#fig2){ref-type="fig"}E and F). Truncation of Bid and mitochondrial cytochrome *c* release are hallmark features of death receptor- and mitochondria-mediated apoptotic pathways, respectively ([@bib29]). Here, we show that 3a-WT protein induced Bid cleavage ([Fig. 3](#fig3){ref-type="fig"}A) and mitochondrial cytochrome *c* release ([Fig. 3](#fig3){ref-type="fig"}B). Taken together, our data demonstrate that the disruption of the CS, YA or DE motif individually does not diminish the ability of 3a to activate the death receptor and mitochondrial apoptotic pathways ([Fig. 3](#fig3){ref-type="fig"}), which is indicative of functional redundancy of these motifs on 3a-induced apoptosis.Fig. 33a induces Bid truncation and mitochondrial cytochrome *C* release. (A) Truncation of Bid was observed when untransfected HEK293 cells were treated with staurosporine (STS). Similar to STS treatment, HEK293 cells transfected with 3a-WT, -CS, -YA, and -DE constructs all showed Bid truncation. Bid: uncleaved Bid (23 kDa); tBid: truncated Bid (16 kDa). (B) Upon STS treatment, cytochrome *c* was detected in the cytosolic fraction of untransfected HEK293 cells. Cytosolic cytochrome *c* was also detected in cells transfected with 3a-WT, -CS, -YA and -DE constructs. Glutamate dehydrogenase (GDH), a mitochondrial marker, was used to demonstrate the cytosolic fractions were free of mitochondrial contamination. Staurosporine (1 μM) was used to induce apoptosis, and β-tubulin was used as loading control.

3.3. 3a mutants are less potent in triggering apoptosis *in vivo*
-----------------------------------------------------------------

We further investigated the pro-apoptotic property of 3a mutants *in vivo*. We previously reported that overexpression of 3a-WT protein caused a rough-eye phenotype, and the eye size was also reduced due to excessive cell death ([@bib39]; [Fig. 4](#fig4){ref-type="fig"}B). In contrast, overexpression of 3a-CS, 3a-YA, and 3a-DE mutants showed only mild rough eye phenotype ([Fig. 4](#fig4){ref-type="fig"}C--E), and the eye size of these flies was also comparable to the *gmr-GAL4* driver control ([Fig. 4](#fig4){ref-type="fig"}A). Nevertheless, we found that both 3a-WT ([Fig. 4](#fig4){ref-type="fig"}G) and 3a mutants ([Fig. 4](#fig4){ref-type="fig"}H--J) caused disruption of external eye morphology by scanning electron microscopy.Fig. 4*In vivo* expression of wild type and mutant 3a disrupt adult eye structures in *Drosophila*. (A--E) Light microscopic examination of adult fly eyes. When compared to the *gmr-GAL4* driver alone control (A), expression of the 3a-WT protein in eye tissues resulted in rough-eye phenotype (B) as characterized by loss of regularity of the adult external eye structure. Expression of mutant 3a proteins (3a-CS, 3a-YA and 3a-DE) showed minimal dominant external eye phenotype (C--E). (F--J) Scanning electron microscopic examination of adult fly eyes. Expression of 3a-WT caused severe loss of sensory bristles (G) when compared to the *gmr-GAL4* control (F); while the expression of 3a-CS, 3a-YA and 3a-DE mutants caused less severe loss of sensory bristles (H--J). Scale bar represents 20 μm.

Acridine orange (AO) staining was performed to determine the pro-apoptotic property of 3a mutants in flies. Acridine orange is a dye which specifically stains apoptotic cells ([@bib10]). As previously reported ([@bib39]), 3a-WT-expressing transgenic animals displayed an increased number of AO-positive cells ([Fig. 5](#fig5){ref-type="fig"}B) when compared to the *gmr-GAL4* driver control ([Fig. 5](#fig5){ref-type="fig"}A). In contrast to 3a-WT, relatively few number of AO-positive cells were detected in 3a-CS, 3a-YA and 3a-DE mutant animals ([Fig. 5](#fig5){ref-type="fig"}C--E). Consistent with the Vero E6 cells data ([Fig. 2](#fig2){ref-type="fig"}), our *in vivo* results further validate the importance of cysteine-rich, Yxxϕ and diacidic domains of 3a ([Fig. 1](#fig1){ref-type="fig"}A) in 3a\'s pro-apoptotic function.Fig. 5*In vivo* expression of wild type and mutant 3a induce apoptosis in *Drosophila*. Acridine orange (AO) staining was performed on third instar larval eye imaginal discs to label apoptotic cells. (A) The *gmr-GAL4* control showed low levels of AO-stained cells. (B) 3a-WT expression induced apoptosis as indicated by an increase in the number of AO-stained cells. The 3a-CS (C), 3a-YA (D) and 3a-DE (E) mutants also induced apoptosis but to a less extent when compared to 3a-WT (B) as indicated by the relatively less number of AO-stained cells detected. Arrows indicate morphogenetic furrows. Scale bar represents 50 μm.

3.4. Ion channel activity of 3a is involved in caspase-dependent apoptosis
--------------------------------------------------------------------------

It was reported that 3a possesses ion channel property ([@bib18]), here we performed electrophysiological measurements to validate the ion channel activity of 3a-WT in mammalian cells ([Fig. 6](#fig6){ref-type="fig"}A and B). Isolated HEK293 cells expressing 3a-WT-EGFP protein were picked according to the GFP signal. Cells expressing 3a-WT-EGFP displayed a larger membrane current over the potential range ([Fig. 6](#fig6){ref-type="fig"}B) when compared to the mock transfected cells ([Fig. 6](#fig6){ref-type="fig"}A). We also detected channel activities in 3a-YA-EGFP and 3a-DE-EGFP-expressing cells ([Fig. 6](#fig6){ref-type="fig"}C and D), however, the activities were found to be different from that observed in 3a-WT-EGFP-expressing cells. Notably, 3a-CS-EGFP-expressing cells displayed whole cell currents that were similar to that of mock transfected cells ([Fig. 6](#fig6){ref-type="fig"}E), indicating the 3a-CS mutant protein lacks ion channel activity. We further found that addition of ion channel blocker barium chloride (Ba) altered the cell membrane current mediated by 3a-WT-EGFP, 3a-YA-EGFP and 3a-DE-EGFP proteins ([Fig. 6](#fig6){ref-type="fig"}B--D). However, Ba displayed no observable effect on 3a-CS-EGFP-expressing cells ([Fig. 6](#fig6){ref-type="fig"}E).Fig. 6Potassium ion channel blockers suppress 3a-WT-induced apoptosis. (A--E) Ion channel properties of 3a. The 3a-WT (B), -YA (C), -DE (D) but not 3a-CS (E) proteins display ion channel activity. The *I*--*V* relationship of mock transfected HEK293 cells (A), and cells transfected with cDNA encoding for 3a-WT-EGFP (B), 3a-YA-EGFP (C) and 3a-DE-EGFP (D) and 3a-CS-EGFP (E) were measured by whole cell patch clamping. Whole cell currents were recorded under voltage steps before (diamond) and 5 min after (square) 10 mM barium chloride (Ba) application. (F) Vero E6 cells transfected with 3a-WT and 3a-CS constructs were treated with potassium ion channel blockers 4-aminopyridine (AP) or barium chloride (Ba). AP or Ba treatment alone only induced minimal nuclear condensation on untransfected cells. Nuclear condensation induced by 3a-WT expression was significantly suppressed by potassium channel blockers (AP and Ba), while such treatments did not result in any significant inhibitory effect on 3a-CS-expressing cells. Untransfected Vero E6 cells treated with 1 μM staurosporine (STS) for 8 h were used as a control because neither AP nor Ba exerted any suppressive effect on STS-induced cell death. Results were plotted as percentage of cells showed nuclear condensation and expressed as means + S.E.M. of three independent experiments. At least 100 cells were counted in each experiment. *\*p* \< 0.05, AP- or Ba-treated 3a-WT-expressing cells versus 3a-WT control.

It has been reported that the Cys^133^ residue of the 3a-WT protein is responsible for homo-dimer/-tetramer formation, and is also essential for 3a\'s ion channel activity ([@bib18]). As ion channel activity has been implicated in apoptosis ([@bib2]), we investigated whether disrupting the ion channel property of 3a would affect its pro-apoptotic function. To intervene the ion channel function we treated 3a-WT-transfected Vero E6 cells with ion channel blockers, 4-aminopyridine (AP) or Ba, and found that both inhibitors were able to suppress 3a-WT-induced nuclear condensation ([Fig. 6](#fig6){ref-type="fig"}F). It has previously been shown that the C133S point mutation ([@bib18]) compromised 3a\'s ion channel activity. As expected, both AP and Ba treatment exerted no further suppressive effect on 3a-CS-induced nuclear condensation ([Fig. 6](#fig6){ref-type="fig"}F). We next fed 3a-WT flies with Ba and determined the extent of 3a-induced apoptosis by AO staining *in vivo*. We found that the number of AO-positive cells was largely reduced in 3a-WT-expressing larvae that were treated with Ba ([Fig. 7](#fig7){ref-type="fig"}C) when compared to the untreated control ([Fig. 7](#fig7){ref-type="fig"}B). As Ba is an inhibitor of the 3a ion channel conductance ([@bib18]; [Fig. 6](#fig6){ref-type="fig"}), both our *in vitro* and *in vivo* data clearly demonstrate a linkage between the pro-apoptotic property and ion channel activity of 3a.Fig. 7Barium chloride treatment suppresses 3a-WT-induced apoptosis in *Drosophila*. Acridine orange (AO) staining in third instar larval eye imaginal discs was performed to identify apoptotic cells in flies. (A) The *gmr-GAL4* control showed low levels of AO-stained cells in third instar imaginal eye discs. (B) 3a-WT expression induced apoptosis as indicated by the increase in the number of AO-stained cells. (C) Feeding 3a-WT-expressing transgenic animals with barium chloride (Ba) reduced the number of AO-stained cells. Arrows indicate morphogenetic furrows. Scale bar represents 50 μm.

4. Discussion
=============

We previously showed that the SARS-CoV 3a protein induces caspase-dependent apoptosis both *in vitro* and *in vitro* ([@bib39], [@bib16]). Various structural/functional domains have been identified in 3a, which include the cysteine-rich, Yxxϕ and diacidic domains ([Fig. 1](#fig1){ref-type="fig"}A; [@bib34]). The cysteine-rich domain is crucial for homo-/hetero-dimerization and ion channel activity of 3a ([@bib18]); while both the Yxxϕ and diacidic domains are well-characterized protein intracellular trafficking signals ([@bib21], [@bib28]). Although the properties of these protein domains have been well characterized, their roles in 3a\'s pro-apoptotic function had not been studied. Although these three domains are located in close proximity, it is possible that each of them is independently responsible for eliciting 3a\'s cellular activities, such as apoptosis induction. In this study, we generated mutant 3a constructs, 3a-CS, 3a-YA and 3a-DE ([Fig. 1](#fig1){ref-type="fig"}A), and investigated the functional significance of the cysteine-rich, Yxxϕ and diacidic domains on 3a\'s pro-apoptotic activity. We previously demonstrated that 3a-WT induces nuclear condensation and DNA fragmentation in Vero E6 cells; 3a-expressing cells are also found to be TUNEL-positive ([@bib16]). Here, we used nuclear condensation as readout to measure the pro-apoptotic potential of 3a mutants. We found that all 3a-CS, 3a-YA and 3a-DE mutant protein-expressing cells possessed reduced caspase activities, and these proteins were also less potent in inducing cell death ([Fig. 2](#fig2){ref-type="fig"}). Consistent with the *in vitro* data, all the 3a mutants displayed diminished pro-apoptotic activities *in vivo*. We observed elevated number of apoptotic cells in flies overexpressed with 3a-WT ([Fig. 5](#fig5){ref-type="fig"}B; [@bib39]), whereas the number of apoptotic cells was much reduced in mutant 3a-expressing flies ([Fig. 5](#fig5){ref-type="fig"}C--E). Altogether, our data clearly show that all cysteine-rich, Yxxϕ and diacidic domains are required for 3a\'s pro-apoptotic function.

We previously reported caspase-8 activation in 3a-WT-expressing Vero E6 cells ([@bib16]), and our *in vivo* data also showed that cytochrome *c* can modulate 3a-WT-induced apoptosis ([@bib39]). As the cytochrome *c*-mediated apoptotic pathway links tightly with caspase-9 activation, in this study we confirmed the involvement of caspase-9 in 3a-WT-induced cell death ([Fig. 2](#fig2){ref-type="fig"}). Indeed, the involvement of caspase-9 in 3a-induced apoptosis has also been reported in a recent study performed by [@bib23]. Both our and others' data indicate that 3a-WT utilizes more than one caspase pathway to trigger cell death. We further showed that both Bid truncation and mitochondrial cytochrome *c* release are involved in 3a-induced apoptosis ([Fig. 3](#fig3){ref-type="fig"}).

As ion channels are known to regulate different phases of apoptosis ([@bib2]) and that 3a possesses potassium-sensitive ion channel activity ([@bib18]), we investigated the relationship between ion channel function and pro-apoptotic potential of 3a. Barium chloride (Ba; [@bib18], [@bib20]) and 4-aminopyridine (AP; [@bib9]) are two commonly used potassium channel blockers. We found that both Ba- and AP-treatment were able to rescue 3a-WT-induced nuclear condensation ([Fig. 6](#fig6){ref-type="fig"}), and a similar suppressive effect was also observed *in vivo* ([Fig. 7](#fig7){ref-type="fig"}). Besides, we further found that the ion channel activity of 3a is linked to caspase-dependent apoptosis. When we co-treated 3a-WT-expressing cells simultaneously with ion channel blocker and broad-range caspase inhibitor, no further inhibition of nuclear condensation was observed ([Fig. 8](#fig8){ref-type="fig"} ). This indicates that the ion channel activity and caspase-induced nuclear condensation of 3a-WT are linked. To conclude, this is the first report which describes the functional significance of 3a\'s ion channel activity in apoptosis induction. Apart from itself being an ion channel, the influence of 3a on the activity of other endogenous ion transporters in viral-infected cells also warrants further investigation.Fig. 8Pro-apoptotic and ion channel activities of 3a are linked. Vero E6 cells, either untransfected or transfected with 3a-WT construct, were treated with general caspase inhibitor (z-VAD-fmk) and/or Ba. z-VAD-fmk and/or barium chloride (Ba) treatment alone only induced minimal nuclear condensation on untransfected cells. Cells transfected with 3a-WT construct displayed nuclear condensation. z-VAD-fmk and/or Ba treatment significantly reduced nuclear condensation induced by 3a-WT expression in Vero E6 cells. Untransfected Vero E6 cells treated with 1 μM staurosporine (STS) for 8 h were used as control, only z-VAD-fmk but not Ba was able to suppress STS-induced nuclear condensation. All results were plotted as percentage of cells that showed nuclear condensation, and were expressed as means + S.E.M. of three independent experiments. At least 100 cells were counted in each experiment. *\*p* \< 0.05, Ba and/or caspase inhibitor-treated 3a-WT-expressing cells versus 3a-WT control.
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